ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

PYC Physiomics Plc

1.25
0.00 (0.00%)
10 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Physiomics Plc LSE:PYC London Ordinary Share GB00BDR6W943 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.25 1.10 1.40 1.25 1.25 1.25 592,472 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 597k -477k -0.0035 -3.57 1.69M
Physiomics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker PYC. The last closing price for Physiomics was 1.25p. Over the last year, Physiomics shares have traded in a share price range of 0.925p to 3.15p.

Physiomics currently has 135,472,478 shares in issue. The market capitalisation of Physiomics is £1.69 million. Physiomics has a price to earnings ratio (PE ratio) of -3.57.

Physiomics Share Discussion Threads

Showing 21501 to 21521 of 30150 messages
Chat Pages: Latest  870  869  868  867  866  865  864  863  862  861  860  859  Older
DateSubjectAuthorDiscuss
10/5/2018
22:10
ADVFN do not ban

You can choose to filter/ignore him.

Remember in his own words he says : "Do not reply derampers. They want to turn board into an arguefest". So anyone who replies to him you are feeding the troll and he thinks you are stupid and weak for doing so.

the stigologist
10/5/2018
22:08
What you're worried about is the realisation of the FACTS I have presented. The fact you want to 'ban' me to hide said facts and probably peddle the lies most of the rampers of this share do is more disingenuous. Nothing I have said is 'negative' unless you think telling the truth and correcting others lies is 'negative'. What you really class as negative is 'any thing you don't like to hear'.
davevt
10/5/2018
18:26
Fool there's plenty of counter arguments to your absolute drivel but I've seen enough of your droning on and on to know they are wasted on you
hms_trader
10/5/2018
18:13
Excellent, another waffler with no clue decides to shut up when he can't counter an argument...
davevt
10/5/2018
17:32
This 500 pound dave chats so much garbage, not even going to waste my time responding
hms_trader
10/5/2018
14:43
why would there be any new entrants? How is pyc ahead of the market when it only does dosage modelling for tumor drugs, when all it's competitors do modelling for design, and dosage, for tumors and hundreds of other diseases. All of these companies are years ahead of pyc who are modelling based on 20 year old tech. Trust me, no one is going to copy what pyc do. The relevance of the patents expiring is it doesn't give pyc any unique IP when people are saying 'they could be bought out'. Come on...
davevt
10/5/2018
14:19
Doesn't matter if the patents have expired as that's no longer the USP, rather it's the data that was acquired since which allowed PYC to fine tune their algos. Any new entrant to the market that replicates the algo will still have a long development curve to acquire the years of data PYC have from the work they've done with their partners, without which they pose no real threat as a formulae is nothing without the right inputs. In this sense PYC is still years ahead if the competition in this field for whom there is a significant barrier to entry.
hms_trader
10/5/2018
10:49
Looking in the wrong place. Thanks for sharing. Will save this one for the toilet! Took a senekot last night, first timer ! LolBring the joy :)
margic
10/5/2018
10:21
I'm surprised you couldn't as they are both on the pyc website.

www.physiomics-plc.com/about-us/technology/

davevt
10/5/2018
09:55
All happened between 2002 & 2004 on the patent front. I do give you this, I can't find the patent numbers after a 10 min search, which in thirsty in 2018 should be enough time.
margic
10/5/2018
09:54
Or chart the story so far again....
margic
10/5/2018
07:59
I think it's you who needs to research.Wayward.
margic
09/5/2018
23:37
And I don't understand what you mean by 'half expect some results soon'. Results from what? It doesn't matter what Merck's results are with their trial, you're not invested in Merck. If you mean what is the result of pycs modelling? Then they give Merck a model, and we already know how much that costs and we already know in advance what we are getting for it. If it matters to you how well Merck have done with their cancer drug, it failed lung and stomach cancer trials in Feb this year.
davevt
09/5/2018
23:31
Margic, I don't know why you're getting excited 'now' about clinical trials with Merck, pyc were doing clinical trials with them, not pre clinical, in 2015. Check the 3rd March 2015 rns.
davevt
09/5/2018
22:42
Yes, that's correct, 20 years. It's priority filing date was 1996.
davevt
09/5/2018
21:28
Follow the VT clinical clues. What the Merck deal will be all about. Clinicals, nice ring to it that. Think we can half expect some results from that soon imo.
margic
09/5/2018
21:15
Unless you know otherwise?
siddle
09/5/2018
21:15
Patents are 20 years.
siddle
09/5/2018
19:32
I wasn't no.
margic
09/5/2018
19:24
Are you aware the patents for systemCell have now expired. It has no true worth now. And yes it may well do clinical trials. But they are years apart. Like I said it takes years to develop a new drug.
davevt
09/5/2018
19:14
It’s worth holding but don’t put everything including kitchen sink into it.
smcl
Chat Pages: Latest  870  869  868  867  866  865  864  863  862  861  860  859  Older

Your Recent History

Delayed Upgrade Clock